{"id":18847,"date":"2024-05-26T20:59:58","date_gmt":"2024-05-26T18:59:58","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&#038;p=18847"},"modified":"2026-04-18T11:23:32","modified_gmt":"2026-04-18T09:23:32","slug":"tirzepatide-15mg","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/cs\/produkt\/tirzepatide-15mg\/","title":{"rendered":"GLP1+GIP 15 mg injek\u010dn\u00ed lahvi\u010dka"},"content":{"rendered":"<div data-elementor-type=\"product-post\" data-elementor-id=\"18847\" class=\"elementor elementor-18847\" data-elementor-post-type=\"product\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5398a95 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5398a95\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b04e45a\" data-id=\"b04e45a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-eff25d0 elementor-widget elementor-widget-text-editor\" data-id=\"eff25d0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h2 data-start=\"242\" data-end=\"313\">Thirzepatide 15mg - chemick\u00e1 struktura a molekul\u00e1rn\u00ed charakteristika<\/h2><p data-start=\"315\" data-end=\"569\">Tirzepatid 15 mg je syntetick\u00fd peptid navr\u017een\u00fd jako du\u00e1ln\u00ed agonista receptor\u016f GLP-1R a GIPR. Molekula se skl\u00e1d\u00e1 z modifikovan\u00e9 sekvence aminokyselin nav\u00e1zan\u00e9 na lipidov\u00fd \u0159et\u011bzec, kter\u00fd umo\u017e\u0148uje reverzibiln\u00ed vazbu na albumin.<\/p><p data-start=\"571\" data-end=\"790\">Pou\u017eit\u00ed strukturn\u00edch modifikac\u00ed (v\u010detn\u011b z\u00e1m\u011bn aminokyselin za \u00fa\u010delem zv\u00fd\u0161en\u00ed odolnosti v\u016f\u010di enzymatick\u00e9 degradaci a acylaci) prodlu\u017euje polo\u010das rozpadu a metabolickou stabilitu v biologick\u00e9m prost\u0159ed\u00ed.<\/p><p data-start=\"792\" data-end=\"965\">Molekulov\u00e1 hmotnost tirzepatydu je p\u0159ibli\u017en\u011b 4813 Da, co\u017e jej klasifikuje jako vysokomolekul\u00e1rn\u00ed komplexn\u00ed peptid, typick\u00fd pro inkretinov\u00e1 analoga nov\u00e9 generace.<\/p><p data-start=\"967\" data-end=\"1202\">Strukturn\u00ed studie nazna\u010duj\u00ed, \u017ee konformace molekuly umo\u017e\u0148uje selektivn\u00ed vazbu na transmembr\u00e1nov\u00e9 dom\u00e9ny receptor\u016f GLP-1R a GIPR, co\u017e vede k aktivaci intracelul\u00e1rn\u00ed signalizace z\u00e1visl\u00e9 na Gs proteinech a zv\u00fd\u0161en\u00ed cAMP.<\/p><hr data-start=\"1204\" data-end=\"1207\" \/><h2 data-start=\"1209\" data-end=\"1257\">Thirzepatide 15 mg jako laboratorn\u00ed \u010dinidlo<\/h2><p data-start=\"1259\" data-end=\"1372\">Ve v\u00fdzkumn\u00e9 komunit\u011b se tirzepatide 15 mg pou\u017e\u00edv\u00e1 jako referen\u010dn\u00ed materi\u00e1l v projektech zam\u011b\u0159en\u00fdch na:<\/p><ul data-start=\"1374\" data-end=\"1546\"><li data-start=\"1374\" data-end=\"1414\"><p data-start=\"1376\" data-end=\"1414\">farmakologie inkretinov\u00fdch receptor\u016f,<\/p><\/li><li data-start=\"1415\" data-end=\"1435\"><p data-start=\"1417\" data-end=\"1435\">Signalizace GPCR,<\/p><\/li><li data-start=\"1436\" data-end=\"1478\"><p data-start=\"1438\" data-end=\"1478\">regulace metabolismu gluk\u00f3zy a lipid\u016f,<\/p><\/li><li data-start=\"1479\" data-end=\"1546\"><p data-start=\"1481\" data-end=\"1546\">integrace mechanism\u016f kontroly chuti k j\u00eddlu a energetick\u00e9 rovnov\u00e1hy.<\/p><\/li><\/ul><p data-start=\"1548\" data-end=\"1683\">Du\u00e1ln\u00ed aktivace receptor\u016f umo\u017e\u0148uje analyzovat synergick\u00e9 \u00fa\u010dinky osy GIP\/GLP-1 na bun\u011b\u010dn\u00fdch a preklinick\u00fdch modelech.<\/p><p data-start=\"1685\" data-end=\"1872\">Studie in vitro uk\u00e1zaly, \u017ee aktivace t\u011bchto receptor\u016f vede ke zv\u00fd\u0161en\u00ed cAMP, modulaci genov\u00e9 exprese souvisej\u00edc\u00ed s metabolismem gluk\u00f3zy a vlivu na mitochondri\u00e1ln\u00ed aktivitu.<\/p><hr data-start=\"1874\" data-end=\"1877\" \/><h2 data-start=\"1879\" data-end=\"1922\">Tirzepatid 15 mg v klinick\u00fdch studi\u00edch<\/h2><p data-start=\"1924\" data-end=\"2014\">D\u00e1vka 15 mg byla nejvy\u0161\u0161\u00ed t\u00fddenn\u00ed d\u00e1vkou analyzovanou v klinick\u00fdch programech f\u00e1ze III.<\/p><p data-start=\"2016\" data-end=\"2114\">Ve studii <strong data-start=\"2026\" data-end=\"2040\">SURMOUNT-1<\/strong> zve\u0159ejn\u011bno v <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">New England Journal of Medicine<\/span><\/span> (2022) uv\u00e1d\u00ed:<\/p><ul data-start=\"2116\" data-end=\"2271\"><li data-start=\"2116\" data-end=\"2170\"><p data-start=\"2118\" data-end=\"2170\"><strong>Pr\u016fm\u011brn\u00e9 sn\u00ed\u017een\u00ed hmotnosti ~20,9% po 72 t\u00fddnech,<\/strong><\/p><\/li><li data-start=\"2171\" data-end=\"2222\"><p data-start=\"2173\" data-end=\"2222\"><strong>\u226520% sn\u00ed\u017een\u00ed hmotnosti u v\u00edce ne\u017e 50% \u00fa\u010dastn\u00edk\u016f,<\/strong><\/p><\/li><li data-start=\"2223\" data-end=\"2271\"><p data-start=\"2225\" data-end=\"2271\"><strong>zlep\u0161en\u00ed lipidov\u00fdch a glykemick\u00fdch parametr\u016f.<\/strong><\/p><\/li><\/ul><p data-start=\"2273\" data-end=\"2385\">V programu <strong data-start=\"2285\" data-end=\"2298\">SURPASS-2<\/strong> vyk\u00e1zala v\u00fdznamn\u00e9 sn\u00ed\u017een\u00ed HbA1c ve srovn\u00e1n\u00ed se skupinou <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Semaglutid<\/span><\/span>.<\/p><p data-start=\"2387\" data-end=\"2514\">Bezpe\u010dnostn\u00ed profil byl z\u00e1visl\u00fd na d\u00e1vce a nej\u010dast\u011bji hl\u00e1\u0161en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky byly gastrointestin\u00e1ln\u00ed.<\/p><hr data-start=\"2516\" data-end=\"2519\" \/><h2 data-start=\"2521\" data-end=\"2560\">V\u00fdznam v preklinick\u00fdch modelech<\/h2><p data-start=\"2562\" data-end=\"2628\">V p\u0159edklinick\u00fdch studi\u00edch poskytuje tirzepatide 15 mg model pro anal\u00fdzu:<\/p><ul data-start=\"2630\" data-end=\"2796\"><li data-start=\"2630\" data-end=\"2699\"><p data-start=\"2632\" data-end=\"2699\">vztah mezi d\u00e1vkou a odezvou p\u0159i maxim\u00e1ln\u00ed aktivaci receptoru,<\/p><\/li><li data-start=\"2700\" data-end=\"2739\"><p data-start=\"2702\" data-end=\"2739\">integrace inkretinov\u00e9 signalizace,<\/p><\/li><li data-start=\"2740\" data-end=\"2796\"><p data-start=\"2742\" data-end=\"2796\">\u00fa\u010dinky aktivace GIPR a GLP-1R na metabolismus tk\u00e1n\u00ed.<\/p><\/li><\/ul><p data-start=\"2798\" data-end=\"3001\">Na zv\u00ed\u0159ec\u00edch modelech byly pozorov\u00e1ny zm\u011bny v expresi gen\u016f souvisej\u00edc\u00edch s metabolismem lipid\u016f a regulac\u00ed metabolismu sacharid\u016f, co\u017e je interpretov\u00e1no jako \u00fa\u010dinek integrovan\u00e9 hormon\u00e1ln\u00ed modulace.<\/p><hr data-start=\"3003\" data-end=\"3006\" \/><h2>Povaha v\u00fdrobku<\/h2><p data-start=\"3030\" data-end=\"3292\">Tirzepatid 15 mg nab\u00edzen\u00fd na laboratorn\u00edm trhu je referen\u010dn\u00ed materi\u00e1l ur\u010den\u00fd pouze pro v\u00fdzkumn\u00e9 a analytick\u00e9 pou\u017eit\u00ed (Research Use Only). Nen\u00ed ur\u010den k terapeutick\u00e9mu pou\u017eit\u00ed mimo kontrolovan\u00e9 klinick\u00e9 studie.<\/p><hr data-start=\"3294\" data-end=\"3297\" \/><p data-start=\"3299\" data-end=\"3315\"><a href=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/tirzepatide-15-mg-vial.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-35010 size-medium\" src=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/tirzepatide-15-mg-vial-300x225.png\" alt=\"Tirzepatide 15mg vial \u2013 dual GIP\/GLP-1 research peptide\" width=\"300\" height=\"225\" srcset=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/tirzepatide-15-mg-vial-300x225.png 300w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/tirzepatide-15-mg-vial-768x576.png 768w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/tirzepatide-15-mg-vial-16x12.png 16w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/tirzepatide-15-mg-vial-800x600.png 800w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/tirzepatide-15-mg-vial-64x48.png 64w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/tirzepatide-15-mg-vial.png 1024w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p><p data-start=\"3299\" data-end=\"3315\">V\u011bdeck\u00e9 zdroje:<\/p><ol data-start=\"3317\" data-end=\"3806\"><li data-start=\"3317\" data-end=\"3491\"><p data-start=\"3320\" data-end=\"3491\">Jastreboff AM et al. Tirzepatid jednou t\u00fddn\u011b k l\u00e9\u010db\u011b obezity.<br data-start=\"3394\" data-end=\"3397\" \/><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">New England Journal of Medicine<\/span><\/span>, 2022.<br data-start=\"3444\" data-end=\"3447\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/\" target=\"_new\" rel=\"noopener\" data-start=\"3450\" data-end=\"3491\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/<\/a><\/p><\/li><li data-start=\"3493\" data-end=\"3685\"><p data-start=\"3496\" data-end=\"3685\">Fr\u00edas JP et al. Tirzepatid versus semaglutid jednou t\u00fddn\u011b u pacient\u016f s diabetem 2. typu.<br data-start=\"3588\" data-end=\"3591\" \/><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">New England Journal of Medicine<\/span><\/span>, 2021.<br data-start=\"3638\" data-end=\"3641\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34170647\/\" target=\"_new\" rel=\"noopener\" data-start=\"3644\" data-end=\"3685\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34170647\/<\/a><\/p><\/li><li data-start=\"3687\" data-end=\"3806\"><p data-start=\"3690\" data-end=\"3806\">Min T. et al. Mechanisms of dual GIP\/GLP-1 receptor agonism.<br data-start=\"3750\" data-end=\"3753\" \/><a class=\"decorated-link\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10107501\/\" target=\"_new\" rel=\"noopener\" data-start=\"3756\" data-end=\"3806\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10107501\/<\/a><\/p><\/li><\/ol><hr data-start=\"3294\" data-end=\"3297\" \/><p><strong>V\u00fdrobek je ur\u010den pro v\u011bdeck\u00fd v\u00fdzkum a laboratorn\u00ed anal\u00fdzy. V\u0161echny \u010dl\u00e1nky a informace na t\u011bchto webov\u00fdch str\u00e1nk\u00e1ch slou\u017e\u00ed pouze k informa\u010dn\u00edm a vzd\u011bl\u00e1vac\u00edm \u00fa\u010del\u016fm.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p><strong data-start=\"131\" data-end=\"152\">Tirzepatid 15 mg<\/strong> je modern\u00ed peptid pat\u0159\u00edc\u00ed do skupiny du\u00e1ln\u00edch agonist\u016f receptor\u016f GIP a GLP-1. Molekula byla navr\u017eena pro vysokou metabolickou stabilitu a p\u0159esnou aktivaci inkretinov\u00fdch drah v experiment\u00e1ln\u00edch modelech.<\/p>","protected":false},"featured_media":35010,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[124,111,15],"product_tag":[136],"class_list":{"0":"post-18847","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-produkty-w-fiolce","7":"product_cat-glp1gip","8":"product_cat-laboratory-research","9":"product_tag-fiolka","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-simple"},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/18847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/comments?post=18847"}],"version-history":[{"count":12,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/18847\/revisions"}],"predecessor-version":[{"id":35464,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/18847\/revisions\/35464"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media\/35010"}],"wp:attachment":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media?parent=18847"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_brand?post=18847"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_cat?post=18847"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_tag?post=18847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}